Merck & MRK Stock
Merck & Price Chart
Merck & MRK Financial and Trading Overview
| Merck & stock price | 130.9 USD |
| Previous Close | 108.66 USD |
| Open | 108.4 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 108.34 - 109.9 USD |
| 52 Week Range | 83.39 - 119.65 USD |
| Volume | 7.22M USD |
| Avg. Volume | 7.09M USD |
| Market Cap | 277.6B USD |
| Beta (5Y Monthly) | 0.357746 |
| PE Ratio (TTM) | 21.367188 |
| EPS (TTM) | 0.9 USD |
| Forward Dividend & Yield | 2.92 (2.68%) |
| Ex-Dividend Date | June 14, 2023 |
| 1y Target Est | 124.42 USD |
MRK Valuation Measures
| Enterprise Value | 296.15B USD |
| Trailing P/E | 21.367188 |
| Forward P/E | 12.855464 |
| PEG Ratio (5 yr expected) | 1.9 |
| Price/Sales (ttm) | 4.7969713 |
| Price/Book (mrq) | 5.9272904 |
| Enterprise Value/Revenue | 5.118 |
| Enterprise Value/EBITDA | 13.24 |
Trading Information
Merck & Stock Price History
| Beta (5Y Monthly) | 0.357746 |
| 52-Week Change | 29.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 119.65 USD |
| 52 Week Low | 83.39 USD |
| 50-Day Moving Average | 113.9 USD |
| 200-Day Moving Average | 105.19 USD |
MRK Share Statistics
| Avg. Volume (3 month) | 7.09M USD |
| Avg. Daily Volume (10-Days) | 7.34M USD |
| Shares Outstanding | 2.54B |
| Float | 2.53B |
| Short Ratio | 2.41 |
| % Held by Insiders | 0.088% |
| % Held by Institutions | 77.43% |
| Shares Short | 15.65M |
| Short % of Float | 0.61% |
| Short % of Shares Outstanding | 0.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.8 |
| Trailing Annual Dividend Yield | 2.57% |
| 5 Year Average Dividend Yield | 290.00% |
| Payout Ratio | 0.5547 |
| Last Split Factor | 1048:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 22.51% |
| Operating Margin (ttm) | 32.31% |
| Gross Margin | 72.75% |
| EBITDA Margin | 38.65% |
Management Effectiveness
| Return on Assets (ttm) | 10.89% |
| Return on Equity (ttm) | 29.69% |
Income Statement
| Revenue (ttm) | 57.87B USD |
| Revenue Per Share (ttm) | 22.83 USD |
| Quarterly Revenue Growth (yoy) | -8.90% |
| Gross Profit (ttm) | 42.08B USD |
| EBITDA | 22.37B USD |
| Net Income Avi to Common (ttm) | 13.03B USD |
| Diluted EPS (ttm) | 5.12 |
| Quarterly Earnings Growth (yoy) | -34.50% |
Balance Sheet
| Total Cash (mrq) | 10.39B USD |
| Total Cash Per Share (mrq) | 4.09 USD |
| Total Debt (mrq) | 30.75B USD |
| Total Debt/Equity (mrq) | 65.55 USD |
| Current Ratio (mrq) | 1.444 |
| Book Value Per Share (mrq) | 18.457 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.67B USD |
| Levered Free Cash Flow (ttm) | 9.5B USD |
Profile of Merck &
| Country | United States |
| State | NJ |
| City | Rahway |
| Address | 126 East Lincoln Avenue |
| ZIP | 07065 |
| Phone | 908 740 4000 |
| Website | https://www.merck.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 67000 |
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Q&A For Merck & Stock
What is a current MRK stock price?
Merck & MRK stock price today per share is 130.9 USD.
How to purchase Merck & stock?
You can buy MRK shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Merck &?
The stock symbol or ticker of Merck & is MRK.
Which industry does the Merck & company belong to?
The Merck & industry is Drug Manufacturers-General.
How many shares does Merck & have in circulation?
The max supply of Merck & shares is 2.53B.
What is Merck & Price to Earnings Ratio (PE Ratio)?
Merck & PE Ratio is 145.44444000 now.
What was Merck & earnings per share over the trailing 12 months (TTM)?
Merck & EPS is 0.9 USD over the trailing 12 months.
Which sector does the Merck & company belong to?
The Merck & sector is Healthcare.
Merck & MRK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P 500 INDEX SPX | 5297.1 USD — |
-0.21
|
2.19B USD — | 5296.19 USD — | 5325.49 USD — | — - | 2.19B USD — |
| S&P 500 (Yahoo.com) GSPC | 5297.1 USD — |
-0.21
|
2.18B USD — | 5296.19 USD — | 5325.49 USD — | — - | 2.18B USD — |
| S&P 100 SP100 | 2520.31 USD — |
-0.2
|
1.08B USD — | 2519.75 USD — | 2535.43 USD — | — - | 1.08B USD — |
| Dow Jones Composite Average DJA | 12722.98 USD — |
-0.09
|
541.64M USD — | 12716.77 USD — | 12761.2 USD — | — - | 541.64M USD — |
| Dow Jones Industrial Average DJI | 39869.38 USD — |
-0.1
|
400.56M USD — | 39864.68 USD — | 40051.05 USD — | — - | 400.56M USD — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2637.27 USD — |
-0.85
|
— — | 2637.01 USD — | 2659.02 USD — | — - | — — |
| Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
| The Capital Strength Index seek NQCAPST | 3083.22 USD — |
+0.23
|
— — | 3081.91 USD — | 3090.56 USD — | — - | — — |
| NYSE ARCA PHARMACEUTICAL INDEX DRG | 1025.39 USD — |
-0.66
|
— — | 1023.01 USD — | 1032.25 USD — | — - | — — |
| NASDAQ OMX CRD Global Sustainab QCRD | 1595.1 USD — |
0
|
— — | — — | — — | — - | — — |
| Better Investing 100 BIXX | 245.36 USD — |
0
|
— — | — — | — — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1440.15 USD — |
-0.41
|
— — | 1436.63 USD — | 1444.16 USD — | — - | — — |
| Nasdaq Factor Family US Low Vol NQFFUSLV | 1574.18 USD — |
+0.32
|
— — | 1570.4 USD — | 1577.36 USD — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| The Capital Strength Net Total NQCAPSTN | 3594.68 USD — |
+0.24
|
— — | 3593.17 USD — | 3603.22 USD — | — - | — — |
- {{ link.label }} {{link}}